The SpaceX Dragon spacecraft launched on a Falcon 9 rocket at 1.29 p.m. EDT on Thursday from NASA s Kennedy Space Center in Florida, the US space agency has said.It i
The SpaceX Dragon spacecraft launched on a Falcon 9 rocket at 1.29 p.m. EDT on Thursday from NASA s Kennedy Space Center in Florida, the US space agency has said.It i
May 19, 2021
The orally administered drug is being tested for treating mild and moderate infection
Optimus Pharma has received the approval of the Drug Controller General of India (DCGI) to conduct Phase III clinical trials of orally administered Molnupiravir capsules on patients with mild and moderate Covid-19 infection.
As per the clinical trial protocols approved, a total of 2,500 subjects in both mild and moderate Covid-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with standard supportive care or standalone standard supportive care.
Treatment modes
The treatment duration is a maximum of five days and the total study duration will be maximum for 29 days from randomisation, the Hyderabad-based company said in a release on Wednesday.